Growth hormone treatment for neurologic symptoms of post‐acute sequelae of COVID‐19

• Main Authors: Traver J. Wright (Author), Melinda Sheffield‐Moore (Author), Richard B. Pyles (Author), Kathleen M. Randolph (Author), Kristen A. McGovern (Author), Christopher P. Danesi (Author), Sarah E. Lindsay (Author), Mohammed F. Zaidan (Author), Brent E. Masel (Author), Randall J. Urban (Author)
• Format: Book
• Published: Wiley, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Following SARS‐CoV‐2 infection, some patients develop lingering neurologic symptoms of post‐acute sequelae of COVID‐19 (PASC) that commonly include fatigue and "brain fog." PASC symptoms are also linked with reduced growth hormone (GH) secretion, but GH treatment has not been test...